Last checked at 20 Jan 2021 13:30
FORM 8.3
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE
1. KEY INFORMATION
| Name of person dealing (Note 1) | Barclays PLC. | |
| Company dealt in | WILLIS TOWERS WATSON PLC | |
| Class of relevant security to which the | ORD | |
| dealings being disclosed relate (Note 2) | ||
| Date of dealing | 19 January 2021 |
2. INTERESTS AND SHORT POSITIONS
(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)
| Class of relevant security: | ORD | ||||
| Long | Short | ||||
Number | (%) | Number | (%) | ||
(1) | Relevant securities |
|
|
|
|
2,519,247 | 1.95% | 598,811 | 0.46% | ||
|
|
|
| ||
(2) | Derivatives (other than options): |
|
|
|
|
272,674 | 0.21% | 445,393 | 0.35% | ||
|
|
|
| ||
(3) | Options and agreements to |
|
|
|
|
| purchase/sell: | 6,000 | 0.00% | 6,000 | 0.00% | |
|
|
|
| ||
(4) | TOTAL: |
|
|
|
|
2,797,921 | 2.17% | 1,050,204 | 0.81% | ||
(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)
Class of relevant security: | Long | Short | ||||
| Number |
| (%) | Number |
| (%) |
(1) Relevant securities |
|
| ||||
(2) Derivatives (other than options) |
|
| ||||
(3) Options and agreements to purchase/sell |
|
| ||||
Total |
|
| ||||
| ||||||
Ap20
1. DEALINGS (Note 4)
(a) Purchases and sales
| Purchase/sale | Number of relevant securities | Price per unit |
| Purchase | 1 | 208.8300 USD |
| Purchase | 2 | 207.3400 USD |
| Purchase | 4 | 208.1200 USD |
| Purchase | 100 | 206.5400 USD |
| Purchase | 100 | 208.7400 USD |
| Purchase | 100 | 208.6750 USD |
| Purchase | 100 | 208.7000 USD |
| Purchase | 200 | 206.4600 USD |
| Purchase | 223 | 206.8836 USD |
| Purchase | 300 | 208.4683 USD |
| Purchase | 320 | 208.5287 USD |
| Purchase | 628 | 207.4215 USD |
| Purchase | 679 | 208.3338 USD |
| Purchase | 725 | 208.0179 USD |
| Purchase | 1,197 | 208.4993 USD |
| Purchase | 1,300 | 208.6657 USD |
| Purchase | 3,613 | 207.8927 USD |
| Purchase | 9,020 | 208.1039 USD |
| Purchase | 9,127 | 208.5000 USD |
| Purchase | 9,522 | 207.5591 USD |
| Purchase | 11,712 | 208.5382 USD |
| Purchase | 64,431 | 208.1962 USD |
| Sale | 1 | 208.8300 USD |
| Sale | 35 | 207.1800 USD |
| Sale | 55 | 207.1900 USD |
| Sale | 61 | 208.2103 USD |
| Sale | 69 | 208.7700 USD |
| Sale | 88 | 208.9000 USD |
| Sale | 93 | 208.4958 USD |
| Sale | 95 | 208.3400 USD |
| Sale | 100 | 207.4000 USD |
| Sale | 100 | 208.4100 USD |
| Sale | 100 | 208.4268 USD |
| Sale | 100 | 208.7200 USD |
| Sale | 100 | 208.8800 USD |
| Sale | 115 | 208.7091 USD |
| Sale | 144 | 207.6197 USD |
| Sale | 184 | 207.7204 USD |
| Sale | 200 | 208.4975 USD |
| Sale | 211 | 208.1425 USD |
| Sale | 216 | 207.5909 USD |
| Sale | 232 | 207.9693 USD |
| Sale | 247 | 207.4944 USD |
| Sale | 253 | 207.1475 USD |
| Sale | 255 | 208.5458 USD |
| Sale | 264 | 207.8569 USD |
| Sale | 284 | 208.4876 USD |
| Sale | 288 | 207.9516 USD |
| Sale | 457 | 207.7366 USD |
| Sale | 497 | 208.5517 USD |
| Sale | 1,070 | 208.8137 USD |
| Sale | 1,072 | 208.4149 USD |
| Sale | 1,125 | 208.1742 USD |
| Sale | 1,877 | 208.2186 USD |
| Sale | 2,002 | 208.4877 USD |
| Sale | 2,019 | 207.9371 USD |
| Sale | 2,601 | 207.9498 USD |
| Sale | 2,984 | 208.3039 USD |
| Sale | 3,322 | 207.6366 USD |
| Sale | 3,683 | 207.7371 USD |
| Sale | 3,798 | 208.0246 USD |
| Sale | 4,651 | 207.9308 USD |
| Sale | 4,814 | 208.2163 USD |
| Sale | 7,161 | 208.0671 USD |
| Sale | 7,445 | 208.0267 USD |
| Sale | 7,775 | 208.3619 USD |
| Sale | 8,712 | 208.5000 USD |
| Sale | 9,718 | 208.5486 USD |
| Sale | 9,991 | 208.3472 USD |
| Sale | 10,090 | 208.5782 USD |
| Sale | 10,573 | 207.4980 USD |
(b) Derivatives transactions (other than options transactions)
Product name, e.g. CFD | Nature of transaction (Note 6) | Number of relevant securities (Note 7) | Price per unit (Note 5) |
|
|
|
|
(c) Options transactions in respect of existing relevant securities
(i) Writing, selling, purchasing or varying
Product name, e.g. call option | Writing, selling, purchasing, varying etc. | Number of securities to which the option relates (Note 7) | Exercise price | Type, e.g. American, European etc. | Expiry date | Option money paid/received per unit (Note 5) |
|
|
|
|
|
|
|
(ii) Exercising
Product name, e.g. call option | Number of securities | Exercise price per unit (Note 5) |
|
|
|
(d) Other dealings (including transactions in respect of new securities) (Note 4)
Nature of transaction (Note 8) | Details | Price per unit (if applicable) (Note 5) |
|
|
|
Ap21
2. OTHER INFORMATION
Agreements, arrangements or understandings relating to options or derivatives
Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.
None
| Is a Supplemental Form 8 (Open Positions) attached? | YES |
| Date of disclosure: | 20 Jan 2021 |
| Contact name: | Large Holdings Regulatory Operations |
| Telephone number: | 020 3134 7213 |
| If a connected EFM, name of offeree/offeror with which connected | |
| If a connected EFM, state nature of connection |
SUPPLEMENTAL FORM 8
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.1 AND RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
DETAILS OF OPEN POSITIONS
(This form should be attached to Form 8.1(a) & (b)(i), Form 8.1(b)(ii) or Form 8.3, as appropriate)
OPEN POSITIONS (Note 1)
| Product name | Written or | Number of | Exercise | Type | Expiry |
| purchased | relevant securities | price | date | ||
| to which the option | |||||
| or derivative |
|
|
| |
| relates |
|
|
| |
| Call Options | Purchased | 6,000 | 220.0000 | American | Jul 16, 2021 |
| Put Options | Purchased | -6,000 | 200.0000 | American | Jul 16, 2021 |
Notes
1. Where there are open option positions or open derivative positions (except for CFDs), full details should be given. Full details of any existing agreements to purchase or to sell must also be given on this form.
2. For all prices and other monetary amounts, the currency must be stated.
For full details of disclosure requirements, see Rule 8 of the Rules. If in doubt, consult the Panel.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210120005409/en/
Copyright Business Wire 2021